NMNAT Enzymes Explained
What NMNAT does
NMNAT (nicotinamide mononucleotide adenylyltransferase) carries out the final step of the NAD+ salvage pathway: converting NMN into NAD+.[1] This conversion is also the final step shared by the other two NAD+ synthesis routes covered on that page, which makes NMNAT a convergence point — essentially every route to NAD+ in a human cell passes through an NMNAT enzyme at the last step.[1]
Three isoforms, three locations
Humans have three distinct NMNAT genes, producing three protein isoforms with different locations inside the cell, established directly by biochemical fractionation and localization studies:[2]
- NMNAT1 is located in the nucleus.
- NMNAT2 is located mainly in the cytosol, enriched at the Golgi apparatus membrane, and is particularly abundant in brain tissue.
- NMNAT3 is located inside mitochondria.
This is not simply three copies of the same tool doing the same job in different rooms. The three isoforms also differ in their biochemical and structural properties — for example, NMNAT1 assembles into a six-part (hexameric) structure while NMNAT3 assembles into a four-part (tetrameric) one — consistent with genuinely distinct, non-redundant roles rather than interchangeable backups for each other.[2]
Why localization matters
NAD+ does not move freely and instantly to wherever it's needed inside a cell, so having a local NAD+-producing enzyme next to local NAD+-consuming enzymes is thought to matter functionally. In the nucleus, NMNAT1 is positioned to supply NAD+ to nuclear NAD+ consumers such as PARP enzymes and sirtuins — see NAD+ and PARPs and NAD+ and Sirtuins.[3] Inside mitochondria, NMNAT3 is positioned to supply the mitochondrial sirtuin SIRT3 and mitochondrial ADP-ribosyltransferases.[3] This compartmentalized picture — separate local NAD+ pools serving separate local consumers, rather than one single interchangeable cellular NAD+ "tank" — is an important, if easy-to-miss, nuance in NAD+ biology.
Where the science is less settled
The specific functional roles just described are reasonably well supported for the nuclear and mitochondrial pools, but isoform biology and localization in this field is an active research area, and some details — like the extent to which NMNAT2's Golgi association versus cytosolic pool serves distinct functions, or how these compartments interact under different physiological conditions — are more context-dependent and less settled than the basic three-location picture. This page describes the well-supported core structure while avoiding overstating how completely every functional detail has been resolved.
What this page is not claiming
NMNAT's enzymatic role and cellular localization are established biochemistry. None of this establishes that an externally supplied NMN supplement reaches, or is limited by, any particular NMNAT isoform or cellular compartment in a way that has been demonstrated to produce a specific health outcome in humans — a separate question covered on NMN Dosage and NMN Safety and Side Effects.
Related reading
For the enzyme that produces NMNAT's substrate, see NAMPT and NAD+ Biosynthesis. For how NMN taken as a supplement actually gets into cells in the first place, see NMN Transport and Cellular Uptake.
- NMNAT converts NMN into NAD+ — the final, shared step of all three NAD+ synthesis routes.
- Three human NMNAT isoforms occupy distinct cellular compartments: NMNAT1 (nucleus), NMNAT2 (cytosol/Golgi), NMNAT3 (mitochondria).
- This compartmentalization suggests separate local NAD+ pools serve separate local NAD+-consuming enzymes, rather than one shared cellular reservoir.
- Some isoform-specific functional details remain an active research area and are less settled than the basic three-location picture.
- Xie N, Zhang L, Gao W, Huang C, Huber PE, Zhou X, Li C, Shen G, Zou B. NAD+ metabolism: pathophysiologic mechanisms and therapeutic potential. Signal Transduction and Targeted Therapy. 2020. doi:10.1038/s41392-020-00311-7. PMID: 33028824.
- Berger F, Lau C, Dahlmann M, Ziegler M. Subcellular compartmentation and differential catalytic properties of the three human nicotinamide mononucleotide adenylyltransferase isoforms. Journal of Biological Chemistry. 2005. doi:10.1074/jbc.M508660200. PMID: 16118205.Primary biochemical/localization study establishing the three-isoform, three-compartment picture.
- Cohen MS. Interplay between compartmentalized NAD+ synthesis and consumption: a focus on the PARP family. Genes & Development. 2020. doi:10.1101/gad.335109.119. PMID: 32029457.Review synthesizing how NMNAT-produced local NAD+ pools serve local NAD+-consuming enzymes.